Department of Urology, School of Medicine, Sapporo Medical University, Hokkaido, Japan.
Department of Urology, Sapporo Central Hospital, Hokkaido, Japan.
Neurourol Urodyn. 2020 Jun;39(5):1330-1337. doi: 10.1002/nau.24383. Epub 2020 May 13.
There have been few reports on whether long-term oral phosphodiesterase 5 inhibitor administration can ameliorate bladder changes due to bladder outlet obstruction (BOO). Therefore, we clarified the chronological changes of the bladder using male BOO rats and evaluated the effects of tadalafil on these changes.
Eight-week-old male Sprague-Dawley rats were used. BOO was created by placing a polyethylene catheter around the urethra. Then, the rats were orally treated with a vehicle, or tadalafil 2 or 10 mg/kg until each evaluation period. Cystometric measurements were performed and the degree of fibrosis in the smooth muscle layer was evaluated at 2, 4, and 16 weeks.
In BOO rats, a significant increase in the number of non-voiding contractions (NVCs) and a shortened intercontraction interval (ICI) were observed in the earlier phase (2 and 4 weeks) compared to Sham rats. In the chronic phase (16 weeks), markedly increased residual urine volume and an extended ICI were observed accompanied by enhanced smooth muscle fibrosis. These results indicated that the bladder in BOO rats represented the overactive phenotype in the earlier phase and changed into the underactive phenotype in the chronic phase. Even in Sham rats, an increased number of NVCs and enhanced fibrosis were observed with time. Tadalafil administration significantly prevented these bladder changes in both BOO and Sham rats.
Long-term oral administration of tadalafil can prevent functional and histological changes in the BOO rat bladder. This agent is also effective for the bladder functional change even in non-obstructed rats.
关于长期口服磷酸二酯酶 5 抑制剂是否能改善膀胱出口梗阻(BOO)引起的膀胱变化,鲜有报道。因此,我们使用雄性 BOO 大鼠阐明了膀胱的时程变化,并评估了他达拉非对这些变化的影响。
8 周龄雄性 Sprague-Dawley 大鼠用于 BOO 模型的建立。通过将聚乙烯导管环绕尿道来创建 BOO。然后,大鼠口服给予载体、或他达拉非 2 或 10mg/kg,直到每个评估时间点。进行膀胱测压,并在 2、4 和 16 周评估平滑肌层纤维化程度。
在 BOO 大鼠中,与 Sham 大鼠相比,在早期阶段(2 周和 4 周)观察到非排尿收缩(NVC)数量显著增加和收缩间期(ICI)缩短。在慢性阶段(16 周),观察到残余尿量明显增加和 ICI 延长,同时伴有平滑肌纤维化增强。这些结果表明,BOO 大鼠的膀胱在早期表现为过度活跃表型,在慢性阶段转变为不活跃表型。即使在 Sham 大鼠中,NVC 的数量也随时间增加,纤维化增强。他达拉非给药可显著预防 BOO 和 Sham 大鼠的这些膀胱变化。
长期口服他达拉非可预防 BOO 大鼠膀胱的功能和组织学变化。该药物对非梗阻大鼠的膀胱功能变化也有效。